Correlation of the BACH1 Pro919Ser polymorphism with breast cancer risk: A literature-based meta-analysis and meta-regression analysis

Experimental and Therapeutic Medicine

Volumn 6, Issue 2, 2013, Pages 435-444

  Shi, Jing ^a   Tong, Jianhua ^a   Cai, Shuang ^a   Qu, Xiujuan ^a   Liu, Yunpeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

BACH1; Breast cancer; Meta analysis; Meta regression analysis; Polymorphism

Indexed keywords

BRCA1 ASSOCIATED C TERMINAL HELICASE 1; BRCA1 PROTEIN; PROLINE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; HUMAN; META ANALYSIS; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879665505     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1148     Document Type: Article

References (34)

1. Benson JR and Jatoi I: The global breast cancer burden. Future Oncol 8: 697-702, 2012.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Wernberg JA, Yap J, Murekeyisoni C, Mashtare T, Wilding GE and Kulkarni SA: Multiple primary tumors in men with breast cancer diagnoses: a SEER database review. J Surg Oncol 99: 16-19, 2009.
5. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 83: 1301-1308, 2000.
6. Pharoah PD, Tyrer J, Dunning AM, Easton DF and Ponder BA; SEARCH Investigators: Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3: e42, 2007.
7. Kuusisto KM, Bebel A, Vihinen M, Schleutker J and Sallinen SL: Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Breast Cancer Res 13: R20, 2011.
8. Cantor SB, Bell DW, Ganesan S, et al: BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105: 149-160, 2001.
9. Song H, Ramus SJ, Kjaer SK, et al: Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS One 2: e268, 2007.
10. Cantor SB and Guillemette S: Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol 7: 253-261, 2011.
11. Vahteristo P, Yliannala K, Tamminen A, Eerola H, Blomqvist C and Nevanlinna H: BACH1 Ser919Pro variant and breast cancer risk. BMC Cancer 6: 19, 2006.
12. Yu X, Chini CC, He M, Mer G and Chen J: The BRCT domain is a phospho-protein binding domain. Science 302: 639-642, 2003.
13. Huo X, Lu C, Huang X, et al: Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol 135: 1569-1575, 2009.
14. Huang J, Tang LL, Hu Z, et al: BRCA1 and BRCA2 gene mutations of familial breast cancer and early-onset breast cancer from Hunan Province in China. China Oncology 18: 566-572, 2008.
15. Cao AY, Huang J, Hu Z, et al: Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 115: 51-55, 2009.
16. Seal S, Thompson D, Renwick A, et al; Breast Cancer Susceptibility Collaboration (UK): Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38: 1239-1241, 2006.
17. Silvestri V, Rizzolo P, Falchetti M, et al: Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy. Breast Cancer Res Treat 126: 539-543, 2011.
18. Loizidou MA, Cariolou MA, Neuhausen SL, et al: Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population. Breast Cancer Res Treat 121: 147-156, 2010.
19. Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J and Durocher F; INHERIT BRCAs: Mutational analysis of the breast cancer susceptibility gene BRIP1/BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families. J Hum Genet 53: 579-591, 2008.
20. Frank B, Hemminki K, Meindl A, et al: BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study. BMC Cancer 7: 83, 2007.
21. García-Closas M, Egan KM, Newcomb PA, et al: Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 119: 376-388, 2006.
22. Rutter JL, Smith AM, Dávila MR, et al: Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Hum Mutat 22: 121-128, 2003.
23. Pabalan N, Jarjanazi H and Ozcelik H: Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 137: 553-558, 2013.
24. Gallo V, Egger M, McCormack V, et al: Strengthening the reporting of observational studies in epidemiology-molecular epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med 8: e1001117, 2011.
25. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002.
26. Zintzaras E and Ioannidis JP: Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28: 123-137, 2005.
27. Ioannidis JP, Patsopoulos NA and Rothstein HR: Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336: 1413-1415, 2008.
28. Peters JL, Sutton AJ, Jones DR, Abrams KR and Rushton L: Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680, 2006.
29. Wong MW, Nordfors C, Mossman D, et al: BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat 127: 853-859, 2011.
30. Cantor S, Drapkin R, Zhang F, et al: The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc Natl Acad Sci USA 101: 2357-2362, 2004.
31. Rosenthal R and DiMatteo MR: Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol 52: 59-82, 2001.
32. Jüni P and Egger M: PRISMAtic reporting of systematic reviews and meta-analyses. Lancet 374: 1221-1223, 2009.
33. Ioannidis JP and Lau J: Pooling research results: benefits and limitations of meta-analysis. Jt Comm J Qual Improv 25: 462-469, 1999.
34. Dennis J, Hawken S, Krewski D, et al: Bias in the case-only design applied to studies of gene-environment and gene-gene interaction: a systematic review and meta-analysis. Int J Epidemiol 40: 1329-1341, 2011.